tiprankstipranks
Advertisement
Advertisement

RYTM Stock Latest News

Rhythm Pharmaceuticals price target raised to $136 from $130 at RBC Capital
The FlyRhythm Pharmaceuticals price target raised to $136 from $130 at RBC Capital
23d ago
RYTM
Rhythm Pharmaceuticals appoints Popovits to board of directors
PremiumThe Fly
Rhythm Pharmaceuticals appoints Popovits to board of directors
25d ago
RYTM
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
PremiumCompany Announcements
Rhythm Pharmaceuticals Gains EMA Backing for IMCIVREE Expansion
1M ago
8K
RYTM
Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $105 from $100 at H.C. Wainwright
1M ago
RYTM
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
PremiumThe Fly
Rhythm Pharmaceuticals selects Pantherx Rare as pharmacy for Imcivree
1M ago
RYTM
Rhythm Wins FDA Nod for Hypothalamic Obesity Therapy
PremiumCompany AnnouncementsRhythm Wins FDA Nod for Hypothalamic Obesity Therapy
1M ago
8K
RYTM
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $149 from $139 at BofA
1M ago
RYTM
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
Premium
TipRanks Newswire
Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)
1M ago
PTN
RYTM
Rhythm Pharmaceuticals price target raised to $142 from $131 at Citi
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $142 from $131 at Citi
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $155 from $152 at Citizens
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $155 from $152 at Citizens
1M ago
RYTM
Rhythm Pharmaceuticals trading resumes
PremiumThe Fly
Rhythm Pharmaceuticals trading resumes
1M ago
RYTM
Rhythm Pharmaceuticals trading halted, news pending
PremiumThe Fly
Rhythm Pharmaceuticals trading halted, news pending
1M ago
RYTM
Rhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
PremiumRatingsRhythm Pharmaceuticals: EMANATE Setback but Validated MC4R Mechanism and Pipeline Optionality Support Lowered $100 Buy Rating
1M ago
RYTM
Rhythm price target lowered to $100 from $110 at H.C. Wainwright
Premium
The Fly
Rhythm price target lowered to $100 from $110 at H.C. Wainwright
1M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $130 from $140 at RBC Capital
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $130 from $140 at RBC Capital
1M ago
RYTM
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
PremiumRatings
Maintaining a Buy: Setmelanotide’s PDUFA Catalyst and Subgroup Signals Offset EMANATE Miss
1M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $139 from $145 at BofA
PremiumThe Fly
Rhythm Pharmaceuticals price target lowered to $139 from $145 at BofA
1M ago
RYTM
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
PremiumRatings
Maintained Buy on Rhythm Pharmaceuticals: EMANATE Setback Offset by Core Obesity Franchise and Pipeline Upside
1M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $136 from $150 at Morgan Stanley
PremiumThe Fly
Rhythm Pharmaceuticals price target lowered to $136 from $150 at Morgan Stanley
1M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $131 from $136 at Citi
PremiumThe FlyRhythm Pharmaceuticals price target lowered to $131 from $136 at Citi
1M ago
RYTM
Rhythm Pharmaceuticals price target lowered to $152 from $176 at Citizens
Premium
The Fly
Rhythm Pharmaceuticals price target lowered to $152 from $176 at Citizens
1M ago
RYTM
Closing Bell Movers: Lensar down 24% on terminated Alcon deal
Premium
The Fly
Closing Bell Movers: Lensar down 24% on terminated Alcon deal
1M ago
AP
BW

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >